Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

Comparative Price Performance Over Time

Compare Price & Volume

Company	Current Price	50-Day Moving Average	52-Week Range	Market Cap	Beta	Avg. Volume	Today's Volume
GKOS Glaukos	$97.76 -1.3%	$98.28	$77.10 ▼ $163.71	$5.66B	0.82	747,037 shs	599,069 shs
IRTC iRhythm Technologies	$136.24 +0.4%	$143.09	$55.92 ▼ $157.13	$4.33B	1.41	491,474 shs	433,891 shs
NARI Inari Medical	$79.97	$79.97	$39.76 ▼ $79.99	$4.68B	1.02	1.47 million shs	N/A
WRBY Warby Parker	$23.92 +2.0%	$21.23	$12.46 ▼ $28.68	$2.45B	2.09	2.01 million shs	1.62 million shs

The 10 Best AI Stocks to Own in 2025

Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.

Get This Free Report

Compare Price Performance

Company	1-Day Performance	7-Day Performance	30-Day Performance	90-Day Performance	1-Year Performance
GKOS Glaukos	+0.48%	-7.18%	-1.03%	+9.80%	-20.26%
IRTC iRhythm Technologies	-0.91%	+0.78%	-6.34%	+34.47%	+34.16%
NARI Inari Medical	0.00%	0.00%	0.00%	0.00%	+36.42%
WRBY Warby Parker	+2.42%	+5.53%	+7.34%	+64.57%	+41.88%

Compare MarketRank™

Company	Overall Score	Analyst's Opinion	Short Interest Score	ESG Score	News and Social Media Sentiment	Company Ownership	Earnings & Valuation
GKOS Glaukos	4.3769 of 5 stars	4.4	1.0	4.4	2.7	1.7	0.6
IRTC iRhythm Technologies	1.1666 of 5 stars	2.5	1.0	0.0	2.7	0.8	0.6
NARI Inari Medical	0.2636 of 5 stars	1.1	0.0	0.0	0.0	2.5	0.6
WRBY Warby Parker	2.5666 of 5 stars	2.3	5.0	0.0	2.0	3.3	0.6

Compare Analyst Forecasts

Company	Consensus Rating Score	Consensus Rating	Consensus Price Target	% Upside from Current Price
GKOS Glaukos	2.75	Moderate Buy	$134.67	37.75% Upside
IRTC iRhythm Technologies	2.90	Moderate Buy	$137.30	0.78% Upside
NARI Inari Medical	2.14	Hold	$69.22	-13.44% Downside
WRBY Warby Parker	2.53	Moderate Buy	$22.88	-4.37% Downside

Current Analyst Ratings Breakdown

Latest WRBY, GKOS, NARI, and IRTC Analyst Ratings

Date	Company	Brokerage	Action	Rating	Price Target
7/15/2025	IRTC iRhythm Technologies	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Lower Price Target	Overweight ➝ Overweight	$160.00 ➝ $147.00
7/14/2025	GKOS Glaukos	BTIG Research Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
7/10/2025	WRBY Warby Parker	JMP Securities Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Market Outperform ➝ Market Perform
7/10/2025	WRBY Warby Parker	Citizens Jmp Subscribe to MarketBeat All Access for the recommendation accuracy rating	Downgrade	Outperform ➝ Market Perform
6/11/2025	IRTC iRhythm Technologies	Morgan Stanley Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Overweight ➝ Overweight	$130.00 ➝ $160.00
5/29/2025	WRBY Warby Parker	Piper Sandler Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Overweight ➝ Overweight	$20.00 ➝ $25.00
5/22/2025	IRTC iRhythm Technologies	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Boost Price Target	Buy ➝ Buy	$130.00 ➝ $167.00
5/22/2025	WRBY Warby Parker	Roth Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$18.00 ➝ $21.00
5/21/2025	WRBY Warby Parker	Cowen Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/21/2025	WRBY Warby Parker	Loop Capital Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Buy ➝ Buy
5/21/2025	WRBY Warby Parker	Citigroup Subscribe to MarketBeat All Access for the recommendation accuracy rating	Reiterated Rating	Neutral ➝ Neutral	$17.00 ➝ $22.00

(Data available from 7/18/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)

Compare Sales & Book Value

Company	Annual Revenue	Price/Sales	Cashflow	Price/Cash	Book Value	Price/Book
GKOS Glaukos	$383.48M	14.57	N/A	N/A	$13.91 per share	7.03
IRTC iRhythm Technologies	$591.84M	7.35	N/A	N/A	$2.90 per share	46.98
NARI Inari Medical	$493.63M	9.48	$0.09 per share	906.95	$8.07 per share	9.91
WRBY Warby Parker	$771.32M	3.24	$0.35 per share	69.07	$3.35 per share	7.14

Compare Profitability & Earnings

Company	Net Income	EPS	Trailing P/E Ratio	Forward P/E Ratio	P/E Growth	Net Margins	Return on Equity (ROE)	Return on Assets (ROA)	Next Earnings Date
GKOS Glaukos	-$146.37M	-$2.37	N/A	N/A	N/A	-31.40%	-10.66%	-8.06%	7/30/2025 (Estimated)
IRTC iRhythm Technologies	-$113.29M	-$3.14	N/A	N/A	N/A	-15.90%	-101.04%	-9.55%	7/30/2025 (Estimated)
NARI Inari Medical	-$1.64M	-$1.35	N/A	727.00	N/A	-13.68%	-10.09%	-6.60%	N/A
WRBY Warby Parker	-$20.39M	-$0.12	N/A	239.20	N/A	-1.79%	-2.48%	-1.29%	8/7/2025 (Confirmed)

Latest WRBY, GKOS, NARI, and IRTC Earnings

Date	Quarter	Company	Consensus Estimate	Reported EPS	Beat/Miss	Gap EPS	Revenue Estimate	Actual Revenue
8/7/2025	Q2 2025	IRTC iRhythm Technologies	-$0.53	N/A	N/A	N/A	N/A	N/A
8/7/2025	Q2 2025	WRBY Warby Parker	$0.09	N/A	N/A	N/A	$212.42 million	N/A
7/30/2025	Q2 2025	GKOS Glaukos	-$0.26	N/A	N/A	N/A	$115.49 million	N/A
5/1/2025	Q1 2025	IRTC iRhythm Technologies	-$0.89	-$0.95	-$0.06	-$0.97	$153.39 million	$158.68 million
4/30/2025	Q1 2025	GKOS Glaukos	-$0.33	-$0.22	+$0.11	-$0.32	$102.78 million	$106.66 million

Compare Dividends

Company	Annual Payout	Dividend Yield	3-Year Dividend Growth	Payout Ratio	Years of Consecutive Growth
GKOS Glaukos	N/A	N/A	N/A	N/A	N/A
IRTC iRhythm Technologies	N/A	N/A	N/A	N/A	N/A
NARI Inari Medical	N/A	N/A	N/A	N/A	N/A
WRBY Warby Parker	N/A	N/A	N/A	N/A	N/A

Compare Debt

Company	Debt-to-Equity Ratio	Current Ratio	Quick Ratio
GKOS Glaukos	0.09	6.49	5.62
IRTC iRhythm Technologies	7.47	5.71	5.58
NARI Inari Medical	N/A	1.77	1.40
WRBY Warby Parker	N/A	2.70	2.30

Compare Ownership

Institutional Ownership

Company	Institutional Ownership
GKOS Glaukos	99.04%
IRTC iRhythm Technologies	N/A
NARI Inari Medical	90.98%
WRBY Warby Parker	93.24%

Insider Ownership

Company	Insider Ownership
GKOS Glaukos	5.80%
IRTC iRhythm Technologies	1.10%
NARI Inari Medical	10.60%
WRBY Warby Parker	18.24%

Compare Miscellaneous Stats

Company	Employees	Shares Outstanding	Free Float	Optionable
GKOS Glaukos	780	57.14 million	53.83 million	Optionable
IRTC iRhythm Technologies	2,000	31.92 million	31.57 million	Optionable
NARI Inari Medical	800	58.54 million	52.34 million	Optionable
WRBY Warby Parker	3,780	104.50 million	85.44 million	Optionable

WRBY, GKOS, NARI, and IRTC Headlines

Recent News About These Companies

Warby Parker to Announce Second Quarter 2025 Financial Results August 7, 2025

July 17 at 4:05 PM | businesswire.com

CenterBook Partners LP Invests $1.42 Million in Warby Parker Inc. (NYSE:WRBY)

July 17 at 9:54 AM | marketbeat.com

Head to Head Comparison: Warby Parker (WRBY) & Its Rivals

July 17 at 4:03 AM | americanbankingnews.com

Warby Parker Inc. (NYSE:WRBY) Shares Bought by Bank of New York Mellon Corp

July 16 at 3:39 AM | marketbeat.com

Warby Parker (NYSE:WRBY) Stock Price Up 5.9% - Here's Why

July 14, 2025 | marketbeat.com

Warby Parker Inc. (NYSE:WRBY) Shares Sold by TimesSquare Capital Management LLC

July 14, 2025 | marketbeat.com

Contrasting Warby Parker (WRBY) & The Competition

July 14, 2025 | americanbankingnews.com

Warby Parker (NYSE:WRBY) Cut to Market Perform at Citizens Jmp

July 13, 2025 | americanbankingnews.com

Warby Parker's (WRBY) Market Perform Rating Reiterated at JMP Securities

July 13, 2025 | americanbankingnews.com

JMP Securities Downgrades Warby Parker (WRBY)

July 11, 2025 | msn.com

Warby Parker (NYSE:WRBY) Receives "Market Perform" Rating from JMP Securities

July 10, 2025 | marketbeat.com

Warby Parker (NYSE:WRBY) Stock Rating Lowered by Citizens Jmp

July 10, 2025 | marketbeat.com

Warby Parker Inc. Stock Grades | WRBY - Barron's

July 10, 2025 | barrons.com

Warby Parker Inc. (NYSE:WRBY) Receives $22.88 Average PT from Analysts

July 9, 2025 | americanbankingnews.com

Winners And Losers Of Q1: Warby Parker (NYSE:WRBY) Vs The Rest Of The Beauty and Cosmetics Retailer Stocks

July 8, 2025 | msn.com

Warby Parker Inc. (NYSE:WRBY) Given Consensus Recommendation of "Moderate Buy" by Brokerages

July 6, 2025 | marketbeat.com

11,751 Shares in Warby Parker Inc. (NYSE:WRBY) Acquired by Diversified Trust Co

July 2, 2025 | marketbeat.com

What Makes Warby Parker (WRBY) an Attractive Investment?

June 30, 2025 | finance.yahoo.com

Bessemer Group Inc. Has $1.17 Million Stock Position in Warby Parker Inc. (NYSE:WRBY)

June 30, 2025 | marketbeat.com

WRBY - Warby Parker Inc Ordinary Shares - Class A Chart - Morningstar

June 28, 2025 | morningstar.comM

The 5 Most Interesting Analyst Questions From Warby Parker’s Q1 Earnings Call

June 27, 2025 | msn.com

New MarketBeat Followers Over Time

Media Sentiment Over Time

WRBY, GKOS, NARI, and IRTC Company Descriptions

Glaukos NYSE:GKOS

$97.76 -1.24 (-1.25%)

Closing price 03:59 PM Eastern

Extended Trading

$97.72 -0.04 (-0.04%)

As of 06:50 PM Eastern

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

iRhythm Technologies NASDAQ:IRTC

$136.24 +0.48 (+0.35%)

Closing price 04:00 PM Eastern

Extended Trading

$136.28 +0.04 (+0.03%)

As of 07:31 PM Eastern

iRhythm Technologies, Inc., a digital healthcare company, engages in the design, development, and commercialization of device-based technology to provide ambulatory cardiac monitoring services to diagnose arrhythmias in the United States. It offers Zio services, an ambulatory monitoring solution, including long-term and short-term continuous monitoring and mobile cardiac telemetry monitoring services. The company also provides the Zio Monitor System, a prescription-only, remote electrocardiogram (ECG) monitoring system that consists of a patch ECG monitor that records the electric signal from the heart continuously for up to 14 days and the Zio ECG Utilization Software System, which supports the capture and analysis of ECG data recorded by the Zio Monitor patch at the end of the wear period, including specific arrhythmia events detected by the ZEUS System; the Zio XT System is the previous generation of the Zio Monitor System and is a prescription-only, remote ECG monitoring system that consists of the Zio XT patch that records the electric signal from the heart continuously for up to 14 days; and the Zio AT system, a prescription-only, remote ECG monitoring system that similarly consists of the Zio AT patch that records the electric signal from the heart continuously for up to 14 days and the ZEUS System, but which also incorporates the Zio AT wireless gateway that provides connectivity between the Zio AT patch and the ZEUS System during the patient wear period. It has a development collaboration agreement with Verily Life Sciences LLC and Verity Ireland Limited to develop various next-generation atrial fibrillation screening, detection, or monitoring products. The company was incorporated in 2006 and is headquartered in San Francisco, California.

Inari Medical NASDAQ:NARI

Inari Medical, Inc. builds minimally invasive, novel, and catheter-based mechanical thrombectomy devices and accessories for the specific disease states in the United States. The company provides ClotTriever system, which is designed to core, capture, and remove large clots from large vessels for treatment of deep vein thrombosis and peripheral thrombus; FlowTriever system, a large bore catheter-based aspiration and mechanical thrombectomy system to remove large clots from large vessels in the peripheral vasculature for treating pulmonary embolism and other complex venous thromboembolism cases; InThrill system to treat small vessel thrombosis; and LimFlow system for patients who have chronic limb-threatening ischemia with no suitable endovascular or surgical revascularization options and risk of major amputation. It serves interventional radiologists, interventional cardiologists, and vascular surgeons. The company was formerly known as Inceptus Newco1 Inc. and changed its name to Inari Medical, Inc. in September 2013. Inari Medical, Inc. was incorporated in 2011 and is headquartered in Irvine, California.

Warby Parker NYSE:WRBY

$23.92 +0.47 (+2.00%)

Closing price 03:59 PM Eastern

Extended Trading

$23.92 +0.00 (+0.02%)

As of 05:20 PM Eastern

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.

More Stock Comparisions from MarketBeat

More Stock Ideas from MarketBeat

Stock Lists

Low Priced Stocks

Stocks By Exchange

Latest Stock Ideas

Get 30 Days of MarketBeat All Access for Free

Start Your 30-Day Trial

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Compare Stocks

Comparative Price Performance Over Time